Upload
airwave12
View
461
Download
3
Embed Size (px)
Citation preview
SOLITARY PULMONARY NODULE
INTRODUCTION
• Definition : Opacity with diameter < 3cm
• Larger lesions are called masses• Completely surrounded by lung parenchyma• It occurs in 1 every 500 CXR
Differential DiagnosisNeoplasm-----Malignant Ca bronchus,Metastasis,Alveolar cell,
carcinoma,blastoma,sarcoma plasmacytoma. Benign---Carcinoid tumor, hamartomaInfection/Inflammation-----
pneumonia ,hydatid,rounded atelactasis,sarcoidosis
Vascular lesion-----haematoma,AV malformation
• Pulmonary infarct• Post-traumatic• Congenital---> Sequestration, Bronchogenic cyst, Intrapulmunary
lymph node
• Amyloidosis• Rheumatoid nodules• Plasma cell granulomas
(tuberculoma,histoplasmoma)
• Mucoid impaction• Nipple shadow
Most lesions are found to be granulomas, lung cancers, or
hamartomas
Basic strategy is to identify malignant versus benign
Factors in determining malignancy
• Calcification • Growth • Location • Size • Margin • Cavitation
RISK OF SPN MALIGNANCY
• In patients with melanoma, sarcoma, or testicular carcinoma, a malignant SPN is 2.5 times more likely to be a metastasis than a primary lung cancer
• However, in patients with head and neck squamous cell carcinoma, a malignant SPN is 8 times more likely to be a primary lung cancer.
GROWTH OF A NODULE
• Benign lesions grow slowly with doubling time exceeding 500 days
• A doubling time of less than 20 days signifies inflammatory process
• Always compare the current radiographs with prior ones (if available)
• Malignant nodules grow at a constant rate expressed as doubling time
• This usually falls between 25 and 450 days with a median of 120 days
• An increase of 28% in nodule diameter indicates doubling
CT scan in an 80-year-old man: 2.5-cm right upper lobe nodule at posterior segment
Repeat CT scan 2 months later: Rapid interval enlargement. Volumetric doubling time was 26 days. FNAB revealed mixed small cell and non–small cell carcinoma.
SPN “LOCATION”
• In patients with idiopathic fibrosis, lung cancers more commonly involve periphery of lower lobe
• Benign nodules: Both upper and lower lobes
The right upper lobe is the most common location of lung cancer
HIGH RESOLUTION CT
• HRCT is the most sensitive and specific for assessing the size, shape, calcification and edge of a nodule
• Type 1 Type 2 Type 3 Type 4
Patterns of Margins
• Corona radiata sign• Fine linear strands
extending 4-5 mm outward• Spiculated on CXRs• 84 – 90% are malignant
• Scalloped border Intermediate probability of
cancer• Smooth border suggestive
of benign diagnosis
AIR BRONCHOGRAMS Air bronchograms and
pseudocavitation more commonly malignant
Cavitation with thick (>15 mm vs. < 5 mm) more often
malignant
CALCIFICATION
• Radiographic pattern of calcium deposition is helpful • Benign lesions tend to have central, laminated (bull’s
eye), diffuse or popcorn pattern• Malignant lesions have speckled or eccentric pattern
Calcification
• Laminated or central pattern typical of granuloma
Calcification
• Stippled or eccentric patterns
• Have been associated with cancer
Popcorn Calcification
• Classic “popcorn” pattern often seen in hamartomas
• HRCT can show fat and cartilage in half of cases
CAVITATION
TUBERCULOMA /HISTOPLASMOMA
common in upper lobes and on the right side
0.5-4cm in size
Calcification is diffuse/central
• Common in lower lobes
• 3cm or smaller
• Central calcification producing target appearance
HISTOPLASMOMA
CONTRAST ENHANCED CT
• Contrast-enhanced examinations are performed at 1-minute intervals up to 4 minutes after injection of contrast material
• Enhancement of less than 15 HU after administration of contrast material is strongly indicative of benignity (positive predictive value, approximately 99%).
• False negatives: central noncavitating necrosis and adenocarcinomas (especially bronchioloalveolar cell carcinoma), which may be related to mucin production
• False positives: active inflammatory diseases e.g. organizing pneumonias and granulomas
In summary, behavior after contrast material
administration is sensitive but not specific for malignancy
PET SCAN
• Highly valuable noninvasive tool• It is 95% sensitive for identifying malignancy and 85%
specific • False positive results may occur in lesions that
contain active inflammatory tissue (histoplasmomas)
Uptake of Fluorine 18-flurodeoxyglucose used to measure glucose metabolism.
Most tumors have greater uptake of FDG than normal tissue
Helpful in detection of mediastinal lymph node mets, even when nodes are not enlarged on CT scans
Occult extra thoracic mets and synchronous extra thoracic primary malignancies
• FDG PET examination of an SPN larger than 1 cm in diameter is the best test to determine if a lesion is malignant or benign
FDG PET scan: Lingular nodule (arrow) with SUV of more than 2.5. FNAB revealed carcinoid tumor
BIOPSY
• Transthorathic needle aspiration (NAB) has a sensitivity of 80% to 90%.
• Non specific benign include atypical bronchioloalveolar hyperplasia or inflammation without organisms on a smear or a culture .
• Careful clinical and radiographic follow-up: If further growth occurs, repeat biopsy or resection is indicated.
FNAB results other than a specific malignant or benign diagnosis should be viewed
with caution
IMAGING MANAGEMENT OF INDETERMINATE NODULES
DECISION MAKING
• Review all prior CXR• Get CT scans• If probability of cancer is <10% wait and watch• If it is high thoracotomy should intervene• Bronch & NAB reserved for pt who are reluctant to
go for surgery before Dx
• Most SPNs are found to be granulomas, lung cancers, or hamartomas.
• Benign nodules can be confidently diagnosed if the
lesion is smaller than 3 cm in diameter and exhibits one of following patterns of calcification: central nidus, laminated, popcorn, or diffuse.
• Probability of malignancy is high (90% if patient is older than 60 years) with positive FDG PET findings and low (<5%) with negative FDG PET findings.
• A new persistent nodule that develops during observation is worrisome for malignancy and warrants intervention.
• Nodules with low likelihood for malignancy that are at least 5 mm and smaller than 10 mm can be observed with CT for a 2-year period, while the ones with intermediate or high likelihood for malignancy can be sampled with FNAB or resected.
EXAM QUESTIONS
• 1) a. What do you mean by solitary pulmonary nodule?
• b. What are the methods of investigating it?• c. what are the causes of intrapulmonary nodules? • 2)Right middle zone 3cm in its greater diameter,
discuss the radiological procedure to evaluate the nature of the lesion?
Thank you